Tylenol Maker Kenvue Shares Rebound After Trump Links Drug To Autism
1. Kenvue shares rose over 6% after Trump's controversial remarks. 2. Trump linked Tylenol to autism risk, lacking scientific backing. 3. Analysts see limited stock risk despite negative headlines. 4. Tylenol, consumed weekly by 52 million Americans, faces public scrutiny. 5. Recent studies find no link between Tylenol and autism.